Stay updated with breaking news from Sure Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "OTC/DTC Infectious Disease Diagnostics Market Report 2021" report has been added to ResearchAndMarkets.com's offering. The report has...
Recent Developments - Importance and How to Use This Section Importance of These Developments FemtoDx Launches Rapid At-Home Test Development for COVID-19 FDA approves first at-home coronavirus test Free Home HIV Tests Detect More Infections Biohacking trend supports self testing. PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test Miraca Holdings Inc. and Seventh Sense Biosystems, Inc. Announce Distribution Agreement OraSure Technologies, Inc. Announces Two Acquisitions Mylan signs HIV test commerci...
DNA & RNA Banking Services Market: Comprehensive Study Explore Huge Growth in Future | EasyDNA, Thermo Fisher Scientific, Inc, OraSure Technologies, Inc.,
Published: May 17, 2021 BETHLEHEM, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Scott Gleason has been appointed Senior Vice President Investor Relations and Corporate Communications effective today. Prior to joining OraSure, Mr. Gleason served as the Senior Vice President of Investor Relations and Corporate Strategy for Myriad Genetics, Inc., a leading specialty diagnostic laboratory in the United States focu...